Written by Kimi Dunbar
Spoon Feed
This meta-analysis demonstrated shorter duration of fever and hospital stay in patients with macrolide resistant Mycoplasma pneumoniae treated with tetracyclines compared to macrolides.
Synopsis
This meta-analysis addressed whether tetracyclines outperform macrolides in treating macrolide-resistant Mycoplasma pneumoniae (MRMP) pneumonia in children. Eleven studies, encompassing 1,143 pediatric patients from East Asia, were included. Tetracyclines significantly reduced febrile duration (weighted mean difference, WMD 1.64 days, 95%CI 0.68–2.59) and hospital stays (WMD 1.22 days, 95%CI 0.82–1.62), with higher therapeutic efficacy (odds ratio 0.33, 95%CI: 0.20–0.57). Limitations include regional focus, variability in study design, and safety concerns about tetracycline use in younger children. The authors concluded that tetracyclines are more effective for MRMP pneumonia but emphasized the need for further research to refine guidelines and address safety concerns. (AI-generated)
Atypical treatment for an atypical bug
The prevalence of mycoplasma infection has been on the rise in the United States, following international trends. Further, there has been an emergence of resistance to macrolide treatment, most notably in the western pacific and global southeast, but increasingly in the Americas and Europe, although the proportion remain modest (8.4 and 5.1%, respectively). IDSA guidelines currently recommend treatment with azithromycin as the first line for children with concern for atypical pneumonia (including mycoplasma). This meta-analysis demonstrated shorter duration of fever and hospital stay with use for macrolide-resistant mycoplasma with tetracyclines; however, of the 11 studies included, none were conducted in the U.S. – all were conducted in Asia, with 4 in China, 4 in Japan and 3 in Korea. While this is an interesting study that informs potential second-line treatment for mycoplasma pneumonia, I don’t plan to change my prescribing practices yet. Current rates of macrolide resistance in the U.S. are low, antibiotic resistance patterns vary geographically, and tetracycline alternatives come with significant side effects.
Source
Treatment of Macrolide-resistant Mycoplasma pneumoniae Pneumonia in Children: A Meta-analysis of Macrolides Versus Tetracyclines. Pediatr Infect Dis J. 2024 Oct 2. doi: 10.1097/INF.0000000000004568. Epub ahead of print. PMID: 39383346
